Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

AHA 2026 6 - 9 November 2026

Primary Report of the Ziltivekimab Cardiovascular Outcomes Trial (ZEUS)

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Cardiovascular Disease
Congress oral presentation
Anti-IL antibody
Ziltivekimab
PHASE 3 (RCT)